Drugs and Biologicals, Coverage of, for Label and Off-Label Uses
J6 · Effective Oct 1, 2015
3 active Medicare policies list J9264, and 17 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Apr 1, 2026
17 policies from 15 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J9264 |
|---|---|---|
| Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension) | Not recorded | Covered with conditionsInferred from policy title |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Nab-Paclitaxel (e.g., Abraxane) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Oncology Medications | Jul 1, 2026 | Covered |
| Policy | Effective | Status of J9264 |
|---|---|---|
| NAB-PACLITAXEL; PACLITAXEL PROTEIN-BOUND PARTICLES | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Paclitaxel (Albumin-Bound) (Abraxane; Paclitaxel Albumin-Bound) | Aug 10, 2013 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Paclitaxel Protein-Bound (Abraxane); CP.PHAR.176 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Paclitaxel Protein-Bound Particles (Abraxane) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Paclitaxel Albumin-Bound: Abraxane; Paclitaxel Albumin-Bound | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J9264 |
|---|---|---|
| Abraxane (paclitaxel protein bound) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |